* Inari Medical Inc NARI.OQ reported a quarterly adjusted
loss
of 6 cents per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 9
cents per share.
* Revenue rose 51.1% to $86.75 million from a year ago;
analysts
expected $83.61 million.
* Inari Medical Inc's reported EPS for the quarter was a
loss of 6
cents.
* The mean earnings estimate of analysts had fallen by
about 369.6% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Inari Medical Inc shares had fallen by 12.0% this
quarter and
lost 12.6% so far this year.
* The company reported a quarterly loss of $3.13 million.
* Wall Street's median 12-month price target for Inari
Medical Inc
is $109.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 4 at 09:48 p.m. All
figures in US dollars unless otherwise stated